Literature DB >> 1976728

In vitro solubility of uranium tetrafluoride with oxidizing medium compared with in vivo solubility in rats.

E Ansoborlo1, J Chalabreysse, S Escallon, M H Hengé-Napoli.   

Abstract

A simple in vitro solubility test for uranium tetrafluoride (UF4) was developed to investigate the effects of addition of enzymes, proteins or gases such as O2 to synthetic biological fluid or Gamble solvent. The tests were conducted concomitantly with an in vivo inhalation experiment using male rats. In the presence of Gamble solvent alone, UF4 exhibited class Y behaviour with a dissolution half-time of 300-500 days. However, when oxygen or carbonates were added to the Gamble solvent, UF4 displayed class W behaviour, with a half-time of 25-50 days. Lastly, in the presence of oxygen and pyrogallol, which simulates the action of the enzyme NADPH, the superoxide ion (O2-) was formed, which appears to have a dominant role in the oxidation of U4+ to U6+. Under these conditions UF4 behaved like a class D compound, and had a dissolution half-time of only 2-3 days. These latter results correlated with those of the inhalation experiment in which the dissolution half-time was calculated to be between 2.5 and 5.2 days. The data are also in agreement with urine monitoring data obtained for workers exposed to UF4 over a 20-year period.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976728     DOI: 10.1080/09553009014552031

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  2 in total

1.  In vitro chemical and cellular tests applied to uranium trioxide with different hydration states.

Authors:  E Ansoborlo; J Chalabreysse; M H Hengé-Napoli; E Pujol
Journal:  Environ Health Perspect       Date:  1992-07       Impact factor: 9.031

2.  In Vitro Investigations of Human Bioaccessibility from Reference Materials Using Simulated Lung Fluids.

Authors:  Aurélie Pelfrêne; Mark R Cave; Joanna Wragg; Francis Douay
Journal:  Int J Environ Res Public Health       Date:  2017-01-24       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.